EDEN Intracardiac Electrogram Recording and Classifying System
2 other identifiers
interventional
50
1 country
1
Brief Summary
Background: Heart surgeons use electrocardiogram (ECG) machines to record electrical signals from the heart during procedures. Normal ECG machines connect only to the skin. Special ECG machines connect directly to the heart; they are a safer option during procedures. Researchers want to test a new ECG machine called the EDEN system. Objective: To test the EDEN system in people having heart procedures. The new system will be used along with an approved special ECG machine. Eligibility: People aged 21 years or older who need to have a heart procedure. These procedures can include (1) electrophysiology mapping or ablation; and (2) conduction system pacing. Design: Researchers will review participants' medical records. No extra tests are needed. Participants will have their heart procedure as planned. The EDEN system will be linked to the special ECG used during the procedure. An extra electrode may be placed on the participant's body. Electrodes are small stickers attached to wires that go to the machine. The EDEN system will record and analyze electrical signals already being measured. It will not interfere with participants' care. No medical decisions well be made based on its data. No follow-up visits are needed for this study....
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedStudy Start
First participant enrolled
April 21, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
Study Completion
Last participant's last visit for all outcomes
November 1, 2026
April 16, 2026
March 25, 2026
6 months
August 19, 2025
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Classifier accuracy
The primary endpoint is classification accuracy of EDEN electrograms automated classifications compared with operator-determined classifications of radial depth according to a five-element ordinal scale (cameral, subendocardial, midmyocardial, subepicardial, pericardial). Agreement will be assessed using standard metrics such as concordance.
During intracardiac electrograms procedure
Study Arms (1)
EDEN Intracardiac Electrogram Recording and Classifying System
EXPERIMENTALEDEN will be used to record and classify intracardiac electrograms obtained in the practice of medicine.
Interventions
EDEN will be used to record and classify intracardiac electrograms obtained in the practice of medicine.
Eligibility Criteria
You may qualify if:
- Age \>= 21 years
- Undergoing a medically-necessary invasive cardiac electrophysiology mapping and/or ablation procedure for ventricular arrhythmia, or conduction system pacing procedure
You may not qualify if:
- Does not consent to participate, or unable to consent to participate
- Hemodynamic instability or emergency procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emory University Hospital
Atlanta, Georgia, 30322, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Robert J Lederman, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2025
First Posted
August 22, 2025
Study Start (Estimated)
April 21, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
April 16, 2026
Record last verified: 2026-03-25
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data will be made available by the end of the project or protocol or at the time of associated publication.
- Access Criteria
- BioData Catalyst is supported by NHLBI and access to data is controlled by the NHLBI Data Access Committee (DAC) utilizing the database of Genotypes and Phenotypes (dbGaP) permissions infrastructure. In order to access controlled-access data in BioData Catalyst, an investigator must have an approved Data Access Request (DAR) in dbGaP.
IPD that underline results in a publication will be shared. Medical images will not be shared because of intrinsic inability to protect confidentiality with reasonable effort.